Long-term survival in patients with germ cell testicular cancer: A population-based competing-risks regression analysis

European Journal of Surgical Oncology

Volumn 40, Issue 1, 2014, Pages 103-112

  Gandaglia, G ^a,b   Becker, A ^a,c   Trinh, Q D ^a,d   Abdollah, F ^b   Schiffmann, J ^a,c   Roghmann, F ^a,e   Tian, Z ^a   Montorsi, F ^b   Briganti, A ^b   Karakiewicz, P I ^a   Sun, M ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Cancer specific mortality; Long term survival; Other cancer mortality; Secondary malignancy; Testicular germ cell tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER PATIENT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; SEMINOMA; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

CANCER-SPECIFIC MORTALITY; LONG-TERM SURVIVAL; OTHER-CANCER MORTALITY; SECONDARY MALIGNANCY; TESTICULAR GERM CELL TUMOR;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASMS, SECOND PRIMARY; POISSON DISTRIBUTION; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TIME FACTORS; UNITED STATES;

EID: 84892513734     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2013.09.019     Document Type: Article

References (28)

1. A. Verdecchia, S. Francisci, and H. Brenner et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data Lancet Oncol 8 2007 Sep 784 796
2. A.W. van den Belt-Dusebout, J. Nuver, and R. de Wit et al. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer J Clin Oncol 24 2006 Jan 20 467 475
3. L.B. Travis, S.D. Fossa, and S.J. Schonfeld et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors J Natl Cancer Inst 97 2005 Sep 21 1354 1365
4. L. Richiardi, G. Scelo, and P. Boffetta et al. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries Int J Cancer 120 2007 Feb 1 623 631
5. A.W. van den Belt-Dusebout, R. de Wit, and J.A. Gietema et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer J Clin Oncol 25 2007 Oct 1 4370 4378
6. D. Robinson, H. Moller, and A. Horwich Mortality and incidence of second cancers following treatment for testicular cancer Br J Cancer 96 2007 Feb 12 529 533
7. H.S. Haugnes, G.J. Bosl, and H. Boer et al. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up J Clin Oncol 30 2012 Oct 20 3752 3763
8. G.K. Zagars, M.T. Ballo, A.K. Lee, and S.S. Strom Mortality after cure of testicular seminoma J Clin Oncol 22 2004 Feb 15 640 647
9. N. Howlader, A.M. Noone, and M. Krapcho et al. SEER cancer statistics review, 1975-2009 (Vintage 2009 populations) 2011 National Cancer Institute Bethesda, MD http://seer.cancer.gov/csr/1975-2009-pops09/ based on November 2011 SEER data submission, posted to the SEER web site, April 2012
10. L.A.G. Ries, D. Melbert, and M. Krapcho et al. SEER cancer statistics review, 1975-2004 2004 National Cancer Institute Web site Bethesda, MD http://seercancergov/csr/1975-2004/
11. C.Y. Hu, Y. Xing, J.N. Cormier, and G.J. Chang Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival Cancer 119 10 2013 15 1900 1907
12. J.R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Statist 16 1988 1141 1154
13. P.F. Jason, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
14. H.-G. Muller, and J.-L. Wang Hazard rate estimation under random censoring with varying kernels and bandwidths Biometrics 50 1994 61 76
15. S.D. Fossa, N. Aass, S. Harvei, and S. Tretli Increased mortality rates in young and middle-aged patients with malignant germ cell tumours Br J Cancer 90 2004 Feb 9 607 612
16. H.S. Haugnes, T. Wethal, and N. Aass et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study J Clin Oncol 28 2010 Oct 20 4649 4657
17. F.E. van Leeuwen, A.M. Stiggelbout, and A.W. van den Belt-Dusebout et al. Second cancer risk following testicular cancer: a follow-up study of 1,909 patients J Clin Oncol 11 1993 Mar 415 424
18. D.L. Preston, E. Ron, and S. Tokuoka et al. Solid cancer incidence in atomic bomb survivors: 1958-1998 Radiat Res 168 2007 Jul 1 64
19. J. Pedersen-Bjergaard, G. Daugaard, S.W. Hansen, P. Philip, S.O. Larsen, and M. Rorth Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours Lancet 338 1991 Aug 10 359 363
20. J.A. Gietema, D.T. Sleijfer, and P.H. Willemse et al. Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer Ann Intern Med 116 1992 May 1 709 715
21. T. Wethal, J. Kjekshus, and J. Roislien et al. Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer J Cancer Surviv 1 2007 Mar 8 16
22. C.J. Beard, L.B. Travis, and M.H. Chen et al. Outcomes in stage I testicular seminoma: a population-based study of 9193 patients Cancer 119 2013 Aug 1 2771 2777
23. T. Inoue, T. Ito, and S. Narita et al. Association of BCL10 germ line polymorphisms on chromosome 1p with advanced stage testicular germ cell tumor patients Cancer Lett 240 2006 Aug 18 41 47
24. J.M. Allan Genetic susceptibility to radiogenic cancer in humans Health Phys 95 2008 Nov 677 686
25. X. Wu, M.R. Spitz, and J.J. Lee et al. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants Cancer Prev Res 2 2009 Jul 617 624
26. E. Riballo, S.E. Critchlow, and S.H. Teo et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient Curr Biol 9 1999 Jul 1 699 702
27. P. Albers, W. Albrecht, and F. Algaba et al. EAU guidelines on testicular cancer: 2011 update Eur Urol 60 2011 Aug 304 319
28. L.B. Travis, C. Beard, and J.M. Allan et al. Testicular cancer survivorship: research strategies and recommendations J Natl Cancer Inst 102 2010 Aug 4 1114 1130